Most dyslipidemic conditions have been linked to an increased risk of cardiovascular disease. Over the past few years major advances have been made regarding the genetic and metabolic basis of dyslipidemias. Detailed characterization of the genetic basis of familial lipid disorders and knowledge concerning the effects of environmental factors on the expression of dyslipidemias have increased substantially, contributing to a better diagnosis in individual patients. In addition to these developments, therapeutic options to lower cholesterol levels in clinical practice have expanded even further in patients with familial hypercholesterolemia and in subjects with cardiovascular disease. Finally, promising upcoming therapeutic lipid lowering strategies will be reviewed. All these advances will be discussed in relation to current clinical practice with special focus on common lipid disorders including familial dyslipidemias.

hypercholesterolemia, hyperlipidemia, lipid disorder, Lipoprotein, treatment,
Clinica Chimica Acta
Department of Cardiology

Castro Cabezas, M, Burggraaf, B, & Klop, B. (2018). Dyslipidemias in clinical practice. Clinica Chimica Acta (Vol. 487, pp. 117–125). doi:10.1016/j.cca.2018.09.010